Literature DB >> 1355855

Virulent strains of Toxoplasma gondii comprise a single clonal lineage.

L D Sibley1, J C Boothroyd.   

Abstract

The protozoan Toxoplasma gondii is a prevalent parasite in wild and domestic animals worldwide, being transmitted through the food chain by carnivorous feeding and scavenging. Toxoplasma normally divides asexually to yield a haploid form that can infect virtually any vertebrate but it also has a well defined sexual cycle that occurs exclusively in cats. Toxoplasma has become important as an often fatal opportunistic pathogen in patients with AIDS, although the 15-85% of adult human populations that are chronically infected with T. gondii are typically asymptomatic. Infections in immunocompromised hosts have variable outcomes. For example, only 30 to 50% of AIDS patients that are chronically infected with the parasite develop toxoplasmic encephalitis and only about half of acute maternal infections result in congenital disease of the newborn. T. gondii strains differ in their virulence in animals, but the extent to which different strains are related has not been determined. Here we analyse 28 strains from a variety of hosts on five continents and find that the ten virulent strains have an essentially identical genotype, whereas the nonvirulent strains are moderately polymorphic. These data strongly suggest that virulent strains of T. gondii originated from a single lineage which has remained genetically homogeneous despite being globally widespread, and despite the ability of this organism to reproduce sexually.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355855     DOI: 10.1038/359082a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  218 in total

1.  Aggregation and distribution of strains in microparasites.

Authors:  C C Lord; B Barnard; K Day; J W Hargrove; J J McNamara; R E Paul; K Trenholme; M E Woolhouse
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

2.  Rapid identification of virulent type I strains of the protozoan pathogen Toxoplasma gondii by PCR-restriction fragment length polymorphism analysis at the B1 gene.

Authors:  M E Grigg; J C Boothroyd
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

Review 3.  The development and biology of bradyzoites of Toxoplasma gondii.

Authors:  L M Weiss; K Kim
Journal:  Front Biosci       Date:  2000-04-01

4.  A dibasic motif in the tail of a class XIV apicomplexan myosin is an essential determinant of plasma membrane localization.

Authors:  C Hettmann; A Herm; A Geiter; B Frank; E Schwarz; T Soldati; D Soldati
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

5.  Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation.

Authors:  Y W Zhang; K Kim; Y F Ma; M Wittner; H B Tanowitz; L M Weiss
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

6.  Inbreeding and parasite sex ratios.

Authors:  Sean Nee; Stuart A West; Andrew F Read
Journal:  Proc Biol Sci       Date:  2002-04-07       Impact factor: 5.349

7.  Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii.

Authors:  L David Sibley; Dana G Mordue; Chunlei Su; Paul M Robben; Dan K Howe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-01-29       Impact factor: 6.237

8.  Differential gene expression in mice infected with distinct Toxoplasma strains.

Authors:  Rachel D Hill; Julia S Gouffon; Arnold M Saxton; Chunlei Su
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

9.  Laboratory passage and characterization of an isolate of Toxoplasma gondii from an ocular patient in Korea.

Authors:  Jong-Yil Chai; Aifen Lin; Eun-Hee Shin; Myoung-Don Oh; Eun-Taek Han; Ho-Woo Nan; Soon-Hyung Lee
Journal:  Korean J Parasitol       Date:  2003-09       Impact factor: 1.341

10.  Targeted disruption of the GRA2 locus in Toxoplasma gondii decreases acute virulence in mice.

Authors:  C Mercier; D K Howe; D Mordue; M Lingnau; L D Sibley
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.